Public Calendar: November 27 - December 3, 2016

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name : Robert M. Califf, M.D., Commissioner of Food and Drugs

Event Date : 11/29/2016 - 11/29/2016
Location : Bethesda, MD
Subject : FDA-Project DataSphere (PDS) Symposium III
FDA Participant/Group : N/A
Non FDA Participant/Group : Representatives from Project DataSphere Technologies, Industry, Academia, and Government Research Experts

Event Date : 11/29/2016 - 11/29/2016
Location : Bethesda, MD
Subject : National Institutes of Health Big Data to Knowledge (BD2K) All-Hands Meeting
FDA Participant/Group : N/A
Non FDA Participant/Group : Senior Executives from John Hopkins Medicine and University, Including Presidents, Deans, Directors, and Faculty

Event Date : 11/30/2016 - 11/30/2016
Location : Yonkers, NY
Subject : Drug Development and Food Regulation
FDA Participant/Group : PRISCILLA CONOVER; THERESA MICHELE; STEPHEN OSTROFF;
Non FDA Participant/Group : Marta Tellado (Consumers Union);

Event Date : 12/02/2016 - 12/02/2016
Location : Washington, D.C.
Subject : Careers in Public Service and Regulatory Science
FDA Participant/Group : N/A
Non FDA Participant/Group : Fellows in Training and Residents of Cardiology at the Cardiovascular Clinical Trialist Forum

Event Date : 12/02/2016 - 12/02/2016
Location : Washington, D.C.
Subject : Reception for Cardiovascular Clinical Trialist (CVCT) Forum
FDA Participant/Group : N/A
Non FDA Participant/Group : Cardiovascular Clinical Trialist (CVCT) Forum Participants and Invited Guests

Event Date : 12/02/2016 - 12/02/2016
Location : Washington, DC
Subject : Opioids
FDA Participant/Group : DOUGLAS THROCKMORTON;
Non FDA Participant/Group : Senator Richard Durbin (D-IL);

Event Date : 12/03/2016 - 12/03/2016
Location : Washington, D.C.
Subject : mHealth, eHealth and Biosensor Technologies Use in Clinical Trials
FDA Participant/Group : N/A
Non FDA Participant/Group : Attendees at the 13th Global CardioVascular Clinical Trialists (CVCT) Forum Included a Wide Variety of Stakeholders, Including Representatives from Academia, Industry, Foreign and Domestic Regulatory Bodies, Prestigious Medical Publications, Private Insurers, Payers, and Patient Groups

Event Date : 12/03/2016 - 12/03/2016
Location : Washington, D.C.
Subject : 13th Global CardioVascular Clinical Trialists Forum (CVCT) Dedicated to the Discussion of Clinical Trials in Cardiovascular Disease
FDA Participant/Group : N/A
Non FDA Participant/Group : Stakeholders, Including Representatives from Academia, Industry, Foreign and Domestic Regulatory Bodies, Prestigious Medical Publications, Private Insurers, Payers, and Patient Groups

Official Name : Elizabeth H. Dickinson, Esq., Chief Counsel

No Significant Event

Official Name : Tracey H. Forfa, J.D., Acting Director, Center for Veterinary Medicine

No Significant Event

Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name : Jeremy Sharp, Deputy Commissioner for Policy, Planning, Legislation and Analysis (OPPLA)

No Significant Event

Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name : Peter Lurie, M.D., M.P.H., Associate Commissioner for Policy and Planning

No Significant Event

Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date : 11/30/2016 - 11/30/2016
Location : Philadelphia, PA
Subject : Medical Devices
FDA Participant/Group : N/A
Non FDA Participant/Group : Members of the Wharton School of Business at the University of Pennsylvania

Official Name : Howard Sklamberg, J.D., Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

Event Date : 12/01/2016 - 12/01/2016
Location : Silver Spring, MD
Subject : Stakeholder Discussion-Deeming Rule
FDA Participant/Group : MITCHELL ZELLER; ESHAEL JOHNSON; ANN SIMONEAU; ROBIN APPLEBERRY; RICHARD TURMAN; MICHELE MITAL; DAVID ASHLEY;
Non FDA Participant/Group : Several Representatives from Atria Group, Inc.

Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name : Katie Conover, Acting Associate Commissioner of External Affairs

No Significant Event

Official Name : Luciana Borio, M.D., Acting Chief Scientist

No Significant Event

Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

Event Date : 11/29/2016
Location : Silver Spring, MD
Subject : Menu Labeling
FDA Participant/Group : CARLA STUCKEY; ELIZABETH TURNER;
Non FDA Participant/Group : Carlisle Clarke, Jessica Schulken, Patrick Carroll (Senate Appropriations Committee); Martha Foley, Tom O'Brien (House Appropriations Committee);

Event Date : 12/02/2016
Location : Silver Spring, MD
Subject : Nutrition Labeling
FDA Participant/Group : CARLA STUCKEY; ELIZABETH TURNER; MAREN KAHN;
Non FDA Participant/Group : Carlisle Clark, Jessica Schulken, Patrick Carroll (Senate Appropriations Committee); Martha Foley , Tom O'Brien (House Appropriations Committee);

Official Name : Jim Sigg, Acting Deputy Commissioner for Operations

No Significant Event